Efficacy of 0.1% Xylometazoline-Hydrochloride nasal decongestant spray in Post-operative sign/symptom relief following Septoplasty: A Prospective-experimental Study.

Phase 4

• Conditions: post-operative relief from signs and symptoms following Septoplasty.

• Registration Number: JPRN-UMIN000052217
• Lead Sponsor: one.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-06-01
• Study Start: 2023-09-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

Not provided

Exclusion Criteria

Patients not from UH and CGH of age <15 years and >60 years, admitted for revision surgery or trauma or in which septoplasty was performed along with other nasal procedures like turbinate reduction or functional endoscopic sinus surgery or submucosal resection (SMR), history of acute or chronic rhinosinusitis and obstructive sleep apnoea, perforated nasal septum, insufficient nasal valve, granulomatous condition of the nose and sinuses, pregnancy, craniofacial malformation (cleft palate or cleft lip), HIV or any bleeding diathesis condition, malignancy, allergic rhinitis, usage of antihistamines or anticoagulants, and history of allergies to allocated drugs were excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post-operative septoplasty sign/symptom relief using the assigned drug.

Secondary Outcome Measures

Name	Time	Method
Patient Satisfaction with the assigned drug.